The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus

References

• Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. 2006. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 96:660–666
   PubMed Web of Science ®Google Scholar
• Ali BH, Blunden G, Tanira MO, Nemmar A. 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 46:409–420
   PubMed Web of Science ®Google Scholar
• Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. 2008. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 29:1280–1284
   PubMed Web of Science ®Google Scholar
• Atashak S, Piri M, Jafari A, Azarbayjani MA. 2010. Effects of 10 week resistance training and ginger consumption on C-reactive protein and some cardiovascular risk factors in obese men. PPJ (Iranian Society of Physiology and Pharmacology) 14:318–328
   Google Scholar
• Bhandari U, Kanojia R, Pillai KK. 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97:227–230
   PubMed Web of Science ®Google Scholar
• Black C, Herring M, Hurley D, O’Connor P. 2010. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. Pain 11:894–903
   Google Scholar
• Bordia A, Verma SK, Srivastava KC. 1997. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 56:379–384
   PubMed Web of Science ®Google Scholar
• ElRokh el-SM, Yassin NA, El-Shenawy SM, Ibrahim BM. 2010. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology 18:309–315
   Google Scholar
• Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 130:1124–1131
   PubMed Web of Science ®Google Scholar
• Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, Li Y. 2012. Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evid Based Complement Altern Med 2012: article ID 570948, doi:10.1155/2012/570948
   Google Scholar
• Goyal RK, Kadnur SV. 2006. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 77:160–163
   PubMed Web of Science ®Google Scholar
• Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, YusofI YAM. 2008. Ginger extract (Zingiber Officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics 63:807–813
   PubMed Web of Science ®Google Scholar
• Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang M, Kawada T. 2008. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated down regulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun 373:429–434
   PubMed Web of Science ®Google Scholar
• Islam MS, Choi H. 2008. Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats. J Med Food 11:152–159
   PubMed Web of Science ®Google Scholar
• Kim S, Chun K, Kundu J, Surh Y. 2004. Inhibitory effects pg 6-gingerol on PMA-induced COX-2 expression and activation of NFκB and p38 MAPK in skin mouse. Biofactors 21:27–31
   PubMed Web of Science ®Google Scholar
• Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN. 2007. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 14:123–128
   PubMed Web of Science ®Google Scholar
• Levy A, Simon O. 2009. Six-shogaol inhibits production of tumour necrosis factor alpha, interleukin-1 beta and nitric oxide from lipopolysaccharide-stimulated RAW 264.7 macrophages. West Indian Med J 58:295–300
   PubMed Web of Science ®Google Scholar
• Li Y, Tran VH, Duke CC, Roufogalis BD. 2012. Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review. Evid Based Complement Altern Med 2012: article ID 516870, doi:10.1155/2012/516870
   Google Scholar
• Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE. 2013. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr 2013. 64:682–686
   Google Scholar
• Nammi S, Sreemantula S, Roufogalis BD. 2009. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 104:366–373
   PubMed Web of Science ®Google Scholar
• Navarro JF, Mora C. 2006. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Sci World J 6:908–917
   Google Scholar
• Park K, Chun K, Lee S, Surh Y. 1998. Inhibitory effect of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 129:139–144
   PubMed Web of Science ®Google Scholar
• Pascot A, Lemieux I, Prud’homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, et al. 2001. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007–2014
   PubMed Web of Science ®Google Scholar
• Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. 2011. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol 49:893–897
   PubMed Web of Science ®Google Scholar
• Sharma I, Gusain D, Dixit VP. 1991. Hypolipidaemic and antiatherosclerotic effects of plumbagin in rabbits. Indian J Physiol Pharmacol 35:10–14
   PubMedGoogle Scholar
• Shen C-L, Hong K-J, Kim SW. 2005. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J Med Food 8:149–153
   PubMed Web of Science ®Google Scholar
• Shimoda H, Shan SJ, Tanaka J, Seki A, Seo JW, Kasajima N, Tamura S, et al. 2010. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J Med Food 13:156–162
   Google Scholar
• Shirdel Z, Mirbadalzadeh R, Madani H. 2009. Antidiabetic and antilipidemic effect of ginger in alloxan monohydrate diabetic rats in comparison with glibenclamide. Iran J Diabetes Lipid Disord 9:7–15
   Google Scholar
• Simin L, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, et al. 2007. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 167:1676–1685
   Google Scholar
• Singletary K. 2010. Ginger an overview of health benefits. Nutr Today 45:171–183
   Google Scholar
• Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. 2002. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 67:475–478
   PubMed Web of Science ®Google Scholar
• Tripathi S, Bruch D, Kittur DS. 2007. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 8:1–7
   Google Scholar